W1M Asset Management Ltd purchased a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 10,993 shares of the company’s stock, valued at approximately $1,412,000.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Frazier Financial Advisors LLC purchased a new stake in shares of Merck KGaA during the second quarter valued at $25,000. Rakuten Securities Inc. bought a new stake in Merck KGaA in the 2nd quarter worth about $27,000. Bard Associates Inc. purchased a new position in Merck KGaA in the 2nd quarter worth about $60,000. Kilter Group LLC purchased a new position in Merck KGaA in the 2nd quarter worth about $62,000. Finally, Addison Advisors LLC purchased a new stake in shares of Merck KGaA during the 2nd quarter valued at about $90,000. 0.10% of the stock is owned by institutional investors.
Merck KGaA Stock Up 0.7%
MKGAF opened at $163.21 on Friday. The stock has a market capitalization of $21.09 billion, a price-to-earnings ratio of 24.92 and a beta of 0.96. The firm has a 50 day moving average price of $162.62 and a 200-day moving average price of $148.46. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
